Doctor profile · Federal record
Dr. Erinn Maury, MD
Rheumatology Physician (CMS: Rheumatology) · Millersville, MD
- NPI 1962453332
- Accepts Medicare
- MIPS 75.1 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
231 Najoles RD Ste 160
Millersville, MD 211082649
(410) 787-9400
fax (410) 787-9405
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- February 15, 2024
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Maryland #D0063979
- Medicaid
- MD #410285100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1962453332. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
44,998
Distinct HCPCS
7
Medicare allowed
$416,619
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 38,800 | 18 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 5,281 | 63 | $23 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 433 | 92 | $80 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 224 | 140 | $133 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 166 | 27 | $140 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 72 | 56 | $179 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 22 | 19 | $96 |
In context: peer comparison
Among 1 peers in Millersville Rheumatology Physician, average services per provider: 6,428. This provider delivers 7.0× the peer median.Open Payments
Industry payments received
All-time total
$2,555
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 21 | $415.91 | |
| Abbvie INC. | 23 | $400.32 | |
| Ucb, INC. | 15 | $295.88 | |
| Janssen Biotech, INC. | 6 | $246.92 | |
| Novartis Pharmaceuticals Corporation | 8 | $210.29 | |
| Mallinckrodt Hospital Products INC. | 4 | $139.03 | |
| Pfizer INC. | 5 | $113.86 | |
| Sandoz INC. | 3 | $94.10 | |
| Aurinia Pharma U.S., INC. | 3 | $76.59 | |
| Organon LLC | 3 | $73.84 | |
| Lilly USA, LLC | 3 | $64.73 | |
| Kiniksa Pharmaceuticals International, Plc | 2 | $55.28 | |
| Fresenius Kabi USA, LLC | 2 | $51.91 | |
| GlaxoSmithKline, LLC. | 2 | $43.09 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $40.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
703
Patients
147
Total drug cost
$1,590,762
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 192 | 58 | $15,496 |
| Humira(Cf) Pen (Adalimumab) | Brand | 82 | 0 | $968,998 |
| Methotrexate (Methotrexate Sodium) | Brand | 74 | 33 | $3,651 |
| Prednisone | Generic | 53 | 22 | $730 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 36 | 11 | $2,561 |
| Taltz Autoinjector (Ixekizumab) | Brand | 36 | 0 | $254,327 |
| Otezla (Apremilast) | Brand | 30 | 0 | $144,238 |
| Alendronate Sodium | Generic | 29 | 12 | $351 |
| Meloxicam | Generic | 29 | 0 | $177 |
| Enbrel Sureclick (Etanercept) | Brand | 28 | 0 | $195,978 |
Frequently asked questions
What is Dr. Erinn Maury's medical specialty?
Dr. Erinn Maury practices Rheumatology Physician in Millersville, MD.
Where does Dr. Erinn Maury practice?
Dr. Erinn Maury practices at 231 Najoles RD Ste 160, Millersville, MD 211082649. Office phone: 4107879400.
What is Dr. Erinn Maury's NPI?
Dr. Erinn Maury's National Provider Identifier (NPI) is 1962453332, issued by NPPES.
Does Dr. Erinn Maury accept Medicare assignment?
Yes. Dr. Erinn Maury accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Erinn Maury commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS 96401). Source: CMS Medicare Physician & Other Practitioners file.